B. Karkliauskienės biologinės medicinos kabinetas, IĮ - financials and debts

Company age: 27 y. 10 mo.

Update

B. Karkliauskienės biologinės medicinos kabinetas - Company finances

EUR
2019
From: 2019-01-01
To: 2019-12-31
Financial data
Sales revenue 18,179
Profit before tax 7,033
Net profit 6,681
Equity 5,364
Liabilities -
Non-current assets 1,131
Current assets 4,713
Total assets 5,844
Taxes paid
STI taxes -
Financial indicators
Revenue change y/y -
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 114.3%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 124.6%
Profit margin Net profit margin. Shows the overall profitability of the company. 36.8%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 38.7%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. -

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

B. Karkliauskienės biologinės medicinos kabinetas - Social security debts

The company had no debts to Sodra

B. Karkliauskienės biologinės medicinos kabinetas - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.